Journal
NEPHROLOGY DIALYSIS TRANSPLANTATION
Volume 24, Issue 4, Pages 1338-1340Publisher
OXFORD UNIV PRESS
DOI: 10.1093/ndt/gfn762
Keywords
congenital nephrotic syndrome of the Finnish type; erythropoietin; transferrin; transcobalamin
Categories
Ask authors/readers for more resources
Congenital nephrotic syndrome of the Finnish type (CNF) is due to NPHS1 mutation and is responsible for a variety of urinary protein losses. We report the case of a 4-month-old girl with a particularly severe form (proteinuria similar to 150 g/l) of CNF. She developed severe non-regenerative anaemia requiring bi-monthly blood transfusions despite daily EPO (600 UI/kg) and iron supplementation. Epoetin pharmacokinetics revealed a urinary loss of 27% of the given dose within the first 24 h after IV injection. However, plasma levels remained increased after 24 h (228 UI/l). Plasma transferrin and transcobalamin levels were undetectable. Atransferrinaemia and atranscobalaminaemia seem to be responsible for disturbed erythropoiesis.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available